SG
Publicaties op Oncologisch.com
Biomarker analyses from the phase III gerandomiseerde CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in ...
Subcutaan versus intraveneus nivolumab bij niercelcarcinoom
Belzutifan dosisoptimalisatie bij heldercellig RCC: LITESPARK-013 fase II
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year...